- Another possible treatment against the novel coronavirus disease will enter the final stage of human trials
- The vaccine candidate developed by Sinovac has received approval to proceed to the third phase
- As reported by Agence France-Presse, it is the third in the world to enter the late stages of trials
- Brazil and Bangladesh are among the countries that will try the effectiveness of the said vaccine
Another possible vaccine for the novel coronavirus disease is set to enter the final stage of human trials.
KAMI learned that the vaccine candidate developed by Chinese pharmaceutical firm called Sinovac has been approved to proceed to the third phase of trials.
Based on a report by Agence France-Presse, the said possible treatment against the virus is the “third in the world” to enter the last step before regulatory approval.
Brazil is one of the countries that will try to test the effectiveness of the said vaccine. It will reportedly be administered to volunteers across six states in the said country.
"Trials of CoronaVac, one of the vaccines that has advanced furthest in testing in the world, will begin at the Clinical Hospital of Sao Paulo," said state governor Joao Doria, adding that initial results are expected within 3 months.
Reuters also published an article that revealed Bangladesh will also host the late-stage trial of the said vaccine candidate.
The process could begin next month, with the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) to be at the helm.
“We have given ethical permission for the trial after reviewing the research protocol,” Mahmood Uz Jahan, the director of the Bangladesh Medical Research Council (BMRC), stated in an interview.
The global race in finding the effective vaccine for the novel coronavirus disease continues as the said illness still wreaks havoc in the lives of millions of people.
A few weeks ago, an Italian doctor claimed that the said disease is becoming less dangerous now and it may disappear without the need for a vaccine.
It was also reported that Moderna, a prominent biotechnology firm in the United States, will begin the final trial of its COVID-19 vaccine later this month.
Please like and share our Facebook posts to support KAMI team! Don’t hesitate to comment and share your opinion about our stories either. We love reading about your thoughts!